Due to the heterogeneous nature of disorders it is unlikely that one therapy will provide maximal benefit for all individuals in need of treatment. By leveraging the unique insights of our founders, expert advisors, and patient data from clinical trials, we intend to identify additional mechanisms and pathways that are disrupted in disorders of brain development. To date, the Seaside team has identified additional novel drug treatments that have compelling scientific rationale for treating DBD 's and also fit with company's mission of developing drugs with significant and meaningful benefit. Our goal is to license the best compounds from pharmaceutical companies and rapidly develop these medications for human use.

Next: Library »